Concepedia

Kake Zhao

KZ

Statistics

Publications

6

Citations

262

H-Index

6

Active since

2003

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Kake Zhao is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacy, medicinal chemistry, and pharmacology.

Publications per year

2003–2021

6

Publications

6

From Screening to Targeted Degradation: Strategies for the Discovery and Optimization of Small Molecule Ligands for PCSK9

Whitney L. Petrilli, Gregory C. Adam, Roman S. Erdmann et al. · Cell chemical biology · 2019 · 83 citations · Full text

, , +12

Inhibition of dipeptidyl peptidase IV (DPP IV) by 2-(2-amino-1-fluoro-propylidene)-cyclopentanecarbonitrile, a fluoroolefin containing peptidomimetic

Kake Zhao, Dong Sung Lim, Takashi Funaki et al. · Bioorganic & Medicinal Chemistry · 2003 · 64 citations

, , +11

Discovery of Novel Indoline Cholesterol Ester Transfer Protein Inhibitors (CETP) through a Structure-Guided Approach

Jonathan E. Wilson, Ravi Kurukulasuriya, Mikhail Reibarkh et al. · ACS Medicinal Chemistry Letters · 2016 · 53 citations · Full text

, , +13

Design of potent and selective GPR119 agonists for type II diabetes

Jason W. Szewczyk, John J. Acton, Alan D. Adams et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 31 citations · Full text

, , +10

Invention of MK-8262, a Cholesteryl Ester Transfer Protein (CETP) Inhibitor Backup to Anacetrapib with Best-in-Class Properties

Petr Váchal, Joseph Duffy, Louis‐Charles Campeau et al. · Journal of Medicinal Chemistry · 2021 · 17 citations · Full text

, , +17

1–5 of 6